Abstract
We have modelled the within-patient evolutionary process during HIV infection using different methodologies. New viral strains arise during the course of HIV infection. These multiple strains of the virus are able to use different coreceptors, in particular the CCR5 and the CXCR4 (R5 and X4 phenotypes, respectively) influence the progression of the disease to the AIDS phase. We present a model of HIV early infection and CTLs response which describes the dynamics of R5 quasispecies, specifying the R5 to X4 switch and the effects of the immune response. We illustrate the dynamics of HIV multiple strains in the presence of multidrug HAART therapy. The HAART combined with X4 strain blocker drugs might help to reduce infectivity and lead to slower progression of the disease. On the methodology side, our model represents a paradigm of integrating formal methods and mathematical models as a general framework to study HIV multiple strains during disease progression, and it will inch towards providing help in selecting among vaccines and drug therapies. The results presented here are one of the rare cases of methodological cross comparison (stochastic and deterministic) and a novel implementation of model checking in therapy validation.
References
Agrawal, S., Archer, C., & Schaffer, D. V. (2009). Computational models of the notch network elucidate mechanisms of context-dependent signalling. PLoS Computational Biology, 5(5), e1000390.
Althaus, C. L., & De Boer, R. J. (2008). Dynamics of immune escape during HIV/SIV infection. PLOS Computational Biology, 4(7), e1000103.
Asquith, B., Edwards, C. T. T., Lipsitch, M., & McLean, A. R. (2006). Inefficient cytotoxic T lymphocyte mediated killing of HIV-1 infected cells in vivo. PLOS Biology, 4(4), e90.
Aziz, A., Sanwal, K., Singhal, V., & Brayton, R. (2000). Model checking continuous time Markov chains. ACM Transactions on Computational Logic, 1(1), 162–170.
Baier, C., Haverkort, B., Hermanns, H., & Katoen, J. P. (2003). Model-checking algorithms for continuous-time Markov chains. IEEE Transaction on Software Engineering, 29(6), 524–541.
Borrow, P., Lewicki, H., Wei, X., Horwitz, M. S., Peffer, N., Meyers, H., Nelson, J. A., Gairin, J. E., Hahn, B. H., Oldstone, M. B. A., & Shaw, G. M. (1997). Antiviral pressure exerted by HIV-1 specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nature Medicine, 3, 205–211.
Cannon, M. J., Openshaw, P. J., & Askonas, B. A. (1988). Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. The Journal of Experimental Medicine, 168, 1163–1168.
Carrington, M., & OBrien, S. J. (2003). The influence of HLA genotype on AIDS. Annual Review of Medicine, 54, 535–551.
Casazza, J., Betts, M., Picker, L., & Koup, R. (2001). Decay kinetics of human immunodeficiency virus-specific CD8+ T cells in peripheral blood after initiation of highly active antiretroviral therapy. Journal of Virology, 75, 6508–6516.
Celada, F., & Seiden, P. E. (1996). Affinity maturation and hypermutation in a simulation of the humoral immune response. Journal of Immunology, 26, 1350–1358.
Chao, L., Davenport, M. P., Forrest, S., & Perelson, A. S. (2004). A stochastic model of cytotoxic T cell responses. Theoretical Biology, 228, 227–240.
Ciocchetta, F., & Hillston, J. (2009). Bio-PEPA: a framework for the modelling and analysis of biochemical networks. Theoretical Computer Science, 410(33), 3065–3084.
Clarke, E. M., Grumberg, O., & Peled, D. A. (1999). Model checking. Cambridge: MIT Press.
De Boer, R. J., & Perelson, A. S. (1995). Towards a general function describing T-cell proliferation. Journal of Theoretical Biology, 175, 657–576.
Dybul, M., Fauci, A. S., Bartlett, J. G., Kaplan, J. E., & Pau, A. K. (2002). Panel on clinical practices for treatment of HIV (September 2002): guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Annals of Internal Medicine, 137(2), 381–433.
Finzi, D., Blankson, J., Siliciano, J. D., Margolick, J. B., Chadwick, K., et al. (1999). Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nature Medicine, 5, 512–517.
Fisher, J., Piterman, N., Hajnal, A., & Henzinger, T. A. (2007). Predictive modeling of signalling crosstalk during C. elegans vulval development. PLoS Computational Biology, 3(5), e92.
Fromentin, J., Comet, J. P., Le Gall, P., & Roux, O. (2007). Analysing gene regulatory networks by both constraint programming and model-checking. In The 29th annual international conference of the IEEE EMBS (pp. 4595–4598). Washington: IEEE Press.
Fryer, H. R., Scherer, A., Oxenius, A., Phillips, R., & McLean, A. R. (2009). No evidence for competition between cytotoxic T-lymphocyte responses in HIV-1 infection. Proceeding of Royal Society of Biosciences, 276(1677), 4389–4397.
Ganusov, V. V., & De Boer, R. J. (2005). Estimating costs and benefits of CTL escape mutations in SIV/HIV infection. PLoS Computational Biology, 2(3), e24.
Gray, L., Sterjovski, J., Churchill, M., Ellery, P., Nasr, N., Lewin, S. R., Crowe, S. M., Wesselingh, S. L., Cunningham, A. L., & Gorry, P. R. (2005). Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndrome. Virology, 337, 384–398.
Guermonprez, P., Valladeau, J., Zitvogel, L., Thery, C., & Amigorena, S. (2002). Antigen presentation and T cell stimulation by dendritic cells. Annual Review of Immunology, 20, 621–667.
Haase, A. T. (1999). Population biology of HIV-1 infection: viral and CD4+ T cell demography and dynamics in lymphatic tissues. Annual Review of Immunology, 17, 625–656.
Herbeuval, J. P., Hardy, A. W., Boasso, A., Anderson, S. A., Dolan, M. J., Dy, M., & Shearer, G. M. (2005). Regulation of TNF-related apoptosis-inducing ligand on primary CD4+ T cells by HIV-1: role of type I IFN-producing plasmacytoid dendritic cells. Proceedings of the National Academy of Sciences of the United States of America, 102, 13974–13979.
Ho, D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M., & Markowitz, M. (1995). Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature, 373, 123–126.
Jin, X., Bauer, D. E., Tuttleton, S. E., Lewin, S., Gettie, A., Blanchard, J., Irwin, C. E., Safrit, J. T., Mittler, J., Weinberger, L., Kostrikis, L. G., Zhang, L., Perelson, A. S., & Ho, D. D. (1999). Dramatic rise in plasma viremia after CD8+ T cell depletion in simian immunodeficiency virusinfected macaques. The Journal of Experimental Medicine, 189, 991–998.
Kalams, S. A., Goulder, P. J., Shea, A. K., Jones, N. G., Trocha, A. K., Ogg, G. S., & Walker, B. D. (1999). Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy. Journal of Virology, 73, 6721–6728.
Kaslow, R., Carrington, M., Apple, R., Park, L., Munoz, A., Saah, A. J., Goedert, J. J., Winkler, C., O’Brien, S. J., Rinaldo, C., Detels, R., Blattner, W., Phair, J., Erlich, H., & Mann, D. L. (1996). Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nature Medicine, 2, 405–411.
Kwiatkowska, M., Norman, G., & Parker, D. (2009). Algorithmic bioprocesses: quantitative verification techniques for biological processes. In A. Condon, D. Harel, J. Kok, A. Salomaa, & E. Winfree (Eds.), Natural computing series (pp. 391–409). Berlin: Springer.
Kwiatkowska, The PRISM model checker. Internet Engineering Task Force. http://www.prismmodelchecker.org.
Layne, S. P., Spouge, J. L., & Dembo, M. (1998). Quantifying the infectivity of human immunodeficiency virus. Proceedings of the National Academy of Sciences of the United States of America, 86, 4644–4648.
Li, H., Cao, Y., Petzold, L. R., & Gillespie, D. T. (2008). Algorithms and software for stochastic simulation of biochemical reacting systems. Biotechnology Progress, 24(1), 56–61.
Mansky, L., & Temin, H. (1995). Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. Journal of Virology, 69, 5087–5094.
Mateus, D., Gallois, J. P., Comet, J. P., & Le Gall, P. (2007). Symbolic modeling of genetic regulatory networks. Journal of Bioinformatics and Computational Biology, 5(2B), 627–640.
Matsuyama, T., Kobayashi, N., & Yamamoto, N. (1991). Cytokines and HIV infection: is AIDS a tumor necrosis factor disease? AIDS, 5(12), 1405–1417.
Michie, C. A., McLean, A., Alcock, C., & Beverly, P. C. L. (1992). Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature, 360, 264.
Mittler, J. E., Markowitz, M., Ho, D. D., & Perelson, A. S. (1999). Improved estimates for HIV-1 clearance rate and intracellular delay. AIDS, 13(11), 1415–1417.
Murray, J. M., Kaufmann, G., Kelleher, A. D., & Cooper, D. A. (1998). A model of primary HIV infection. Mathematical Biosciences, 154(5), 57–85.
Ogg, G., Jin, X., Bonhoeffer, S., Moss, P., Nowak, M., Monard, S., Segal, J. P., Cao, Y., Rowland-Jones, S. L., Hurley, A., Markowitz, M., Ho, D. D., McMichael, A. J., & Nixon, D. F. (1999). Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. Journal of Virology, 73, 797–800.
Pantaleo, G., Graziosi, C., & Fauci, A. S. (1993). The immunopathogenesis of human immunodeficiency virus infection. The New England Journal of Medicine, 328, 327–335.
Pavlakis, G. N., Valentin, A., Morrow, M., & Yarchoan, R. (2004). Differential effects of TNF on HIV-1 expression: R5 inhibition and implications for viral evolution. Frederick: International Conference AIDS.
Perelson, A. S., Neumann, A. U., Markowitz, M., Leonard, J. M., & Ho, D. D. (1996). HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science, 271, 1582–1586.
Phillips, B. N. (1996). Reduction of HIV concentration during acute infection: independence from a specific immune response. Science, 271(5248), 497–499.
Phillips, R. E., Rowland-Jones, S., Nixon, D. F., Gotch, F. M., Edwards, J. P., et al. (1991). Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature, 354, 453–459.
Ramratnam, B., Mittler, J. E., Zhang, L., Boden, D., Hurley, A., Fang, F., Macken, C. A., Perelson, A. S., Markowitz, M., & Ho, D. D. (2000). The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy. Nature Medicine, 6, 82–85.
Ramratnam, B., Ribeiro, R., He, T., Chung, C., Simon, V., Vanderhoeven, J., Hurley, A., Zhang, L., Perelson, A. S., Ho, D. D., & Markowitz, M. (2004). Intensification of antiretroviral therapy accelerates the decay of the HIV-1 latent reservoir and decreases, but does not eliminate, ongoing virus replication. Journal of Acquired Immune Deficiency Syndrome, 35, 33–37.
Regev, A., & Shapiro, E. (2002). Cellular abstractions: cells as computation. Nature, 419, 343.
Ribeiro, R. M., Mohri, H., Ho, D. D., & Perelson, A. S. (2002a). Modeling deuterated glucose labeling of T-lymphocytes. Bulletin of Mathematical Biology, 64(2), 385–405.
Ribeiro, R. M., Mohri, H., Ho, D. D., & Perelson, A. S. (2002b). In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: why are CD4+ but not CD8+ T cells depleted? Proceedings of the National Academy of Sciences of the United States of America, 99(24), 15572–15577.
Riddell, S. R., Watanabe, K. S., Goodrich, J. M., Li, C. R., Agha, M. E., & Greenberg, P. D. (1992). Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science, 257, 238–241.
Schmitz, J., Kuroda, M., Santra, S., Sasseville, V., Simon, M., et al. (1999). Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science, 283, 857–860.
Sguanci, L., Bagnoli, F., & Lió, P. (2007). Modeling HIV quasispecies evolutionary dynamics. BMC Evolutionary Biology, 7(2), S5.
Siliciano, J. D., Kajdas, J., Finzi, D., Quinn, T. C., Chadwick, K., et al. (2003). Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4(+) T cells. Nature Medicine, 9, 727–728.
Sorathiya, A., Bracciali, A., & Lió, P. (2010). Formal reasoning on qualitative models of coinfection of HIV and tuberculosis and HAART therapy. BMC Bioinformatics, 11(1), S67.
Stafford, M. A., Corey, L., Cao, Y., Daar, E. S., Ho, D. D., & Perelson, A. S. (2000). Modeling plasma virus concentration during primary HIV infection. Journal of Theoretical Biology, 203(3), 285–301.
Wei, X., Ghosh, S. K., Taylor, M. E., Johnson, V. A., Emini, E. A., Deutsch, P., Lifson, J. D., Bonhoeffer, S., Nowak, M. A., Hahn, B. H., Saag, M. S., & Shaw, G. M. (1995). Viral dynamics in human immunodeficiency virus type 1 infection. Nature, 373, 117–122.
Weinberger, L., & Shenk, T. (2007). An HIV feedback resistor: auto-regulatory circuit deactivator and noise buffer. PLoS Biology, 5, e9.
Weinberger, A. D., Perelson, A. S., Ribeiro, R. M., & Weinberger, L. S. (2009). Accelerated immunodeficiency by anti-CCR5 treatment in HIV infection. PLoS Computational Biology, 5(8), e1000467.
Wiegel, F. W., & Perelson, A. S. (2004). Some scaling principles for the immune system. Immunology and Cell Biology, 82, 127–131.
Wodarz, D., & Nowak, M. A. (2002). HIV dynamics and evolution. BioEssays, 24, 1178–1187.
Zhang, L., Dailey, P. J., He, T., Gettie, A., Bonhoeffer, S., Perelson, A. S., & Ho, D. D. (1999a). Rapid clearance of simian immunodeficiency virus particles from plasma of rhesus macaques. Journal of Virology, 73(1), 855–860.
Zhang, L., Ramratnam, B., Tenner-Racz, K., He, Y., Vesanen, M., et al. (1999b). Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy. New England Journal of Medicine, 340, 1605–1613.
Author information
Authors and Affiliations
Corresponding author
Additional information
This project is supported by EC IST SOCIALNETS—Grant agreement number 217141.
Andrea Bracciali has been supported by an EMBO Short Term Fellowship.
Rights and permissions
About this article
Cite this article
Sorathiya, A., Bracciali, A. & Liò, P. An integrated modelling approach for R5–X4 mutation and HAART therapy assessment. Swarm Intell 4, 319–340 (2010). https://doi.org/10.1007/s11721-010-0046-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11721-010-0046-4